SCHEMBL30725844

SCHEMBL30725844

O=C(Nc1ccc2[nH]nc(-c3cccnc3)c2c1)c1cccc(F)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.64
NTRK1 P04629 2/20 0.59
CLK2 P49760 3/20 0.57
DYRK1A Q13627 3/20 0.57
NPC1 O15118 1/20 0.57
DYRK3 O43781 1/20 0.57
ROCK2 O75116 1/20 0.57
MAP4K4 O95819 1/20 0.57
RPS6KB1 P23443 1/20 0.57
RAB9A P51151 1/20 0.57
CSNK2A1 P68400 1/20 0.57
ROCK1 Q13464 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
MKNK2 Q9HBH9 1/20 0.57
LRRK2 Q5S007 2/20 0.56
BRAF P15056 1/20 0.55
CSF1R P07333 1/20 0.55
AURKA O14965 1/20 0.54
CDK7 P50613 1/20 0.53
ULK1 O75385 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29172484 1.00 PDPK1 (0.64) PDPK1NTRK1CLK2DYRK1ANPC1
SCHEMBL2861637 0.92 PDPK1 (0.59) PDPK1NTRK1CLK2DYRK1ANPC1
SCHEMBL29172502 0.89 DYRK1A (0.61) NTRK1CLK2DYRK1ANPC1RAB9A
SCHEMBL30725858 0.89 DYRK1A (0.61) NTRK1CLK2DYRK1ANPC1RAB9A
SCHEMBL30725877 0.88 CDK7 (0.67) NTRK1CLK2DYRK1ALRRK2AURKA
SCHEMBL29172495 0.88 CDK7 (0.67) NTRK1CLK2DYRK1ALRRK2AURKA
SCHEMBL30725862 0.88 PIM1 (0.60) PDPK1CLK2DYRK1ALRRK2AURKA
SCHEMBL29172527 0.88 PIM1 (0.60) PDPK1CLK2DYRK1ALRRK2AURKA
SCHEMBL5394136 0.85 LRRK2 (0.57) PDPK1DYRK1ANPC1RAB9ALRRK2
SCHEMBL30725856 0.85 LRRK2 (0.68) LRRK2BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117186066-A Indazole ALK5 inhibitor and preparation method and application thereof 中国药科大学 2023-12-08 CN disclosed